entinostat (SNDX-275) - Kyowa Hakko Kirin, Syndax
Entinostat: NDA submission in combination with exemestane for HR+ metastatic breast cancer in 2020 (Syndax) - Aug 8, 2019 - Q2 2019 Results 
NDA
http://ir.syndax.com/static-files/96fb80dc-d47d-4792-9bf8-5cfe4d02d30c
 
Aug 8, 2019
 
 
b01862f8-2e74-4ab6-a40c-6260ff7da823.jpg